| Title : The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala - Miller_2017_J.Pharmacol.Exp.Ther_360_23 |
| Author(s) : Miller SL , Aroniadou-Anderjaska V , Pidoplichko VI , Figueiredo TH , Apland JP , Krishnan JK , Braga MF |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 360 :23 , 2017 |
| Abstract : Miller_2017_J.Pharmacol.Exp.Ther_360_23 |
| ESTHER : Miller_2017_J.Pharmacol.Exp.Ther_360_23 |
| PubMedSearch : Miller_2017_J.Pharmacol.Exp.Ther_360_23 |
| PubMedID: 27799295 |
Miller SL, Aroniadou-Anderjaska V, Pidoplichko VI, Figueiredo TH, Apland JP, Krishnan JK, Braga MF (2017)
The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala
Journal of Pharmacology & Experimental Therapeutics
360 :23
Miller SL, Aroniadou-Anderjaska V, Pidoplichko VI, Figueiredo TH, Apland JP, Krishnan JK, Braga MF (2017)
Journal of Pharmacology & Experimental Therapeutics
360 :23